Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 709

1.

Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.

Retz M, Lehmann J, Amann E, Wullich B, Röder C, Stöckle M.

J Urol. 2003 Jan;169(1):86-9.

PMID:
12478110
[PubMed - indexed for MEDLINE]
2.

Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.

Okegawa T, Kinjo M, Horie S, Nutahara K, Higashihara E.

Urology. 2003 Jul;62(1):182-6.

PMID:
12837463
[PubMed - indexed for MEDLINE]
3.

Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?

Buchumensky V, Klein A, Zemer R, Kessler OJ, Zimlichman S, Nissenkorn I.

J Urol. 1998 Dec;160(6 Pt 1):1971-4.

PMID:
9817302
[PubMed - indexed for MEDLINE]
4.

Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.

Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.

Urology. 2004 Jul;64(1):157-61.

PMID:
15245962
[PubMed - indexed for MEDLINE]
5.

The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine.

Pu XY, Wang ZP, Chen YR, Wang XH, Wu YL, Wang HP.

J Cancer Res Clin Oncol. 2008 Jun;134(6):659-65. Epub 2007 Nov 20.

PMID:
18026991
[PubMed - indexed for MEDLINE]
6.

Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.

Klein A, Zemer R, Buchumensky V, Klaper R, Nissenkorn I.

Cancer. 1998 Jan 15;82(2):349-54.

PMID:
9445193
[PubMed - indexed for MEDLINE]
7.

Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.

Eissa S, Kassim SK, Labib RA, El-Khouly IM, Ghaffer TM, Sadek M, Razek OA, El-Ahmady O.

Cancer. 2005 Apr 1;103(7):1356-62.

PMID:
15717321
[PubMed - indexed for MEDLINE]
Free Article
8.

Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.

Inoue T, Nakanishi H, Inada K, Hioki T, Tatematsu M, Sugimura Y.

J Urol. 2001 Dec;166(6):2134-41.

PMID:
11696722
[PubMed - indexed for MEDLINE]
9.

Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.

Okegawa T, Kinjo M, Nutahara K, Higashihara E.

J Urol. 2004 Apr;171(4):1461-6.

PMID:
15017198
[PubMed - indexed for MEDLINE]
10.

Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer.

Golijanin D, Shapiro A, Pode D.

J Urol. 2000 Dec;164(6):1922-5.

PMID:
11061882
[PubMed - indexed for MEDLINE]
11.

Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.

Guo B, Luo C, Xun C, Xie J, Wu X, Pu J.

Exp Oncol. 2009 Mar;31(1):43-7.

PMID:
19300416
[PubMed - indexed for MEDLINE]
12.

Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma.

Retz M, Lehmann J, Röder C, Plötz B, Harder J, Eggers J, Pauluschke J, Kalthoff H, Stöckle M.

Cancer Res. 1998 Dec 15;58(24):5662-6.

PMID:
9865718
[PubMed - indexed for MEDLINE]
Free Article
13.

Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.

Retz M, Lehmann J, Szysnik C, Zwank S, Venzke T, Röder C, Kalthoff H, Basbaum C, Stöckle M.

Eur Urol. 2004 Mar;45(3):314-9.

PMID:
15036676
[PubMed - indexed for MEDLINE]
14.

Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.

Isurugi K, Suzuki Y, Tanji S, Fujioka T.

J Urol. 2002 Oct;168(4 Pt 1):1574-7.

PMID:
12352460
[PubMed - indexed for MEDLINE]
15.

Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.

Melissourgos N, Kastrinakis NG, Davilas I, Foukas P, Farmakis A, Lykourinas M.

Urology. 2003 Aug;62(2):362-7.

PMID:
12893365
[PubMed - indexed for MEDLINE]
16.

Urinary cytokeratin 20 as a marker for transitional cell carcinoma.

Rotem D, Cassel A, Lindenfeld N, Mecz Y, Sova Y, Resnick M, Stein A.

Eur Urol. 2000 May;37(5):601-4.

PMID:
10765100
[PubMed - indexed for MEDLINE]
17.

Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.

Eissa S, Swellam M, Shehata H, El-Khouly IM, El-Zayat T, El-Ahmady O.

J Urol. 2010 Feb;183(2):493-8. doi: 10.1016/j.juro.2009.10.024. Epub 2009 Dec 14.

PMID:
20006858
[PubMed - indexed for MEDLINE]
18.

Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.

Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.

J Urol. 2002 Aug;168(2):465-9.

PMID:
12131289
[PubMed - indexed for MEDLINE]
19.

The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.

Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, Ciciliato S, Pappagallo GL, Belgrano E, Stanta G.

Eur Urol. 2005 Mar;47(3):327-33. Epub 2004 Dec 2.

PMID:
15716196
[PubMed - indexed for MEDLINE]
20.

Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients.

Kinjo M, Okegawa T, Horie S, Nutahara K, Higashihara E.

Int J Urol. 2004 Jan;11(1):38-43.

PMID:
14678183
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk